Granulocyte colony-stimulating factor enhances the in vitro cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cell lines and primary blast cells-Reference-Cited by-同舟云学术

Granulocyte colony-stimulating factor enhances the in vitro cytotoxicity of gemtuzumab ozogamicin against acute myeloid leukemia cell lines and primary blast cells

Published:2006-01 Issue:1 Volume:34 Page:54-65
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Rutella Sergio,Bonanno Giuseppina,Procoli Annabella,Mariotti Andrea,Lucia M. Barbara,Contemi Anna Maria,Cauda Roberto,Fianchi Luana,Scambia Giovanni,Pagano Livio,Leone Giuseppe

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference37 articles.

1. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia;Bross;Clin Cancer Res,2001

2. Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia;Lo-Coco;Blood,2004

3. Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse;Sievers;J Clin Oncol,2001

4. CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance;Linenberger;Leukemia,2005

5. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling;Crocker;Curr Opin Struct Biol,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Leukemia Stem Cells and the Immunological Bone Marrow Microenvironment;Resistance to Targeted Anti-Cancer Therapeutics;2019

2. Filgrastim enhances T-cell clearance by antithymocyte globulin exposure after unrelated cord blood transplantation;Blood Advances;2018-03-13

3. Targeting Leukemia Stem Cells in the Bone Marrow Niche;Biomedicines;2018-02-21

4. Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia;International Journal of Hematology;2017-05-15

5. Calicheamicin Conjugates: Gemtuzumab Ozogamicin (Mylotarg), Inotuzumab Ozogamicin;Handbook of Therapeutic Antibodies;2014-08-12